Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378309 · ClinicalTrials.gov registry record · NA
Illinois United ePREP Program Evaluation
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 338
- Enrollment target
NCT04378309: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT04378309 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 338 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04378309, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
Study Summary
The current research is designed to implement and evaluate the ePREP relationship intervention with couples throughout the state of Illinois.
Primary Outcome
Couple Satisfaction Index
Interventions
- BEHAVIORAL ePREP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT04378309 record still lists
NCT04378309 is an interventional study that assigns participants to a tested intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 1 intervention - of which ePREP is the first listed.
NCT04378309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04378309 about?
NCT04378309 is a clinical study titled "Illinois United ePREP Program Evaluation". The current research is designed to implement and evaluate the ePREP relationship intervention with couples throughout the state of Illinois.
What is the current status of trial NCT04378309?
This trial is currently completed. It is a NA study. The enrollment target is 338 participants. The study started on 2020-10-15. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04378309?
The interventions under investigation include: ePREP (BEHAVIORAL).
Who is sponsoring clinical trial NCT04378309?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04378309's enrollment target sits among peer trials
338 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI